Par Pharmaceutical (PRX) Tops Q1 EPS by 8c

May 8, 2012 7:31 AM EDT Send to a Friend
Get Alerts PRX Hot Sheet
Price: $49.98 --0%

Financial Fact:
Research and development: 28.46M

Today's EPS Names:
CBNK, HTLD, GRC, More
Trade PRX Now!
Join SI Premium – FREE
Par Pharmaceutical (NYSE: PRX) reported Q1 EPS of $0.80, $0.08 better than the analyst estimate of $0.72. Revenue for the quarter came in at $271.5 million versus the consensus estimate of $230.84 million.

For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment